Chronic Low Back Pain Clinical Trial
Official title:
IVR-based Cognitive Behavior Therapy for Chronic Low Back
The proposed study will test how well an innovative method, interactive voice response (IVR), can be used for delivering an treatment for chronic low back pain. The use of IVR will improve the accessibility of treatment to Veterans. IVR is a computerized interface that allows patients to use their telephone to: 1) obtain pre-recorded didactic information, 2) report data regarding pain-related symptoms and adherence to pain coping skill practice, and 3) receive personalized therapist feedback. Although CBT has been shown to be effective in reducing pain intensity, traditional CBT requires patients to make frequent office visits. The use of IVR will allow Veterans to access CBT from their home via a touch-tone telephone, thereby allowing them to access treatment at their convenience without travel to the VA for an outpatient appointment. Veterans with chronic low back pain will be randomized in equal numbers to receive either standard CBT or IVR-based CBT. Veterans in both conditions will receive 10 session of treatment designed to help them manage their chronic pain using pain coping skills. The primary outcome measure will be pain intensity.
OBJECTIVES: The primary purpose of this study is to test the efficacy of an innovative
method, interactive voice response (IVR), for delivering an empirically validated
psychological (cognitive behavior therapy [CBT]) treatment for chronic pain in order to
improve access and sustainability of this intervention. The primary clinical equivalence
hypothesis states that Veterans with chronic low back pain (CLBP) receiving IVR-based CBT
(ICBT) will demonstrate, relative to standard face-to-face CBT (CBT), equivalent declines in
reports of pain intensity as measured by the numeric rating scale at post-treatment and
follow-up. The secondary hypothesis states that Veterans with CLBP receiving ICBT, relative
to CBT, will demonstrate equivalent declines in reports of pain-related interference and
emotional distress at post-treatment and follow-up.
RESEARCH DESIGN: A randomized design will be employed in which standard CBT (CBT) is compared
to an Interactive CBT (ICBT) treatment condition. Participants will be randomized in equal
numbers to both conditions. Repeated assessments of key outcome domains will occur at
pretreatment/baseline and at 3 and 6 months following baseline.
METHODOLOGY: Subjects will be 230 patients receiving care at the VA Connecticut Healthcare
System who report chronic low back pain. The primary criteria for inclusion are constant pain
of at least three months duration with at least a moderate level of average pain (i.e.,
scores of 4 or greater on a 0 (no pain) to 10 (worst pain imaginable) on a numerical rating
scale of average pain. All patients must have access to a touch-tone telephone. Excluded will
be patients with life threatening or acute physical illness, current alcohol or substance
abuse or dependence, current psychosis, suicidal ideation, dementia, and individuals seeking
surgical pain treatment. Comprehensive evaluations will be conducted at each assessment
interval. Following completion of written consent and an initial baseline evaluation,
participants will be randomized to one of the two treatments. Sessions will be audiotaped to
ensure the fidelity of the face-to-face CBT sessions and the personalized therapist feedback
in the IVR-based CBT condition. Both conditions will involve 10 outpatient therapy sessions
with a psychologist trained experienced in the delivery of these treatments. Adherence to
coping skill practice will be assessed using IVR for both treatment groups. Analysis of
primary and secondary outcome measures will employ mixed-effects models, which will account
for the clustering induced by repeated measures on individual patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |